Pamela A. Christopherson

ORCID: 0000-0001-6758-9815
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Platelet Disorders and Treatments
  • Blood groups and transfusion
  • Blood disorders and treatments
  • Heparin-Induced Thrombocytopenia and Thrombosis
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Autoimmune Bullous Skin Diseases
  • Immunodeficiency and Autoimmune Disorders
  • Diabetes Treatment and Management
  • Complement system in diseases
  • Coagulation, Bradykinin, Polyphosphates, and Angioedema
  • Hemophilia Treatment and Research
  • Genomic variations and chromosomal abnormalities
  • Cell Adhesion Molecules Research
  • Blood Coagulation and Thrombosis Mechanisms
  • Renal Diseases and Glomerulopathies
  • Bone health and treatments
  • Osteoarthritis Treatment and Mechanisms
  • Venous Thromboembolism Diagnosis and Management
  • Protease and Inhibitor Mechanisms
  • Bone Metabolism and Diseases
  • Gastrointestinal Bleeding Diagnosis and Treatment
  • Obstructive Sleep Apnea Research
  • Bone and Dental Protein Studies
  • Hemostasis and retained surgical items

Versiti Blood Center of Wisconsin
2014-2024

Washington University in St. Louis
2023

Medical College of Wisconsin
2002-2016

Zimmerman Associates (United States)
2013

Children's Hospital of Wisconsin
2002-2006

University of Miami
2001

Pfizer (United States)
1999

Howard Hughes Medical Institute
1998

Weatherford College
1998

Summary Bleeding Assessment Tools (BATs) have been developed to aid in the standardized evaluation of bleeding symptoms. The Vicenza Questionnaire (BQ), published 2005, established a common framework and scoring key that has undergone subsequent modification over years, culminating publication ISTH‐BAT 2010. Understanding normal range scores is critical when assessing utility BAT. Within context Merging Project, bioinformatics system was created facilitate merging legacy data derived from...

10.1111/hae.12503 article EN Haemophilia 2014-09-06

BACKGROUND von Willebrand factor (VWF) is a multimeric protein that binds platelets and collagen, facilitating hemostasis at sites of vessel injury. Measurement VWF multimer distribution critical for diagnosis variant disease (VWD), particularly types 2A 2B, but the typical measurement by gel electrophoresis technically difficult time-consuming. A comparison collagen binding (VWF:CB) was performed to evaluate utility VWF:CB as diagnostic test. METHODS Participants were enrolled in Zimmerman...

10.1373/clinchem.2012.199000 article EN Clinical Chemistry 2013-01-23

BackgroundBleeding assessment tools are key screening tests used in the evaluation of patients with suspected inherited bleeding disorders. The International Society on Thrombosis and Haemostasis-Scientific Standardization Committee endorsed Bleeding Assessment Tool (ISTH-BAT) has differing reference ranges for adult males (0-3), females (0-5), children (0-2), reflecting symptoms exposure to hemostatic challenges these healthy population subgroups. Age is known markedly impact score...

10.1016/j.jtha.2022.11.045 article EN cc-by Journal of Thrombosis and Haemostasis 2023-01-08

Abstract Radiographic mammary microcalcifications are one of the most pertinent diagnostic markers breast cancer. Breast tissue calcification in form calcium hydroxyapatite (HA) is strongly associated with malignant disease. We tested hypothesis that HA may exert biological effects on surrounding cells, thereby facilitating cancer progression. Our findings showed crystals enhanced mitogenesis cell lines MCF‐7 and Hs578T also normal human epithelial cells. were found to upregulate production...

10.1002/mc.1070 article EN Molecular Carcinogenesis 2001-10-22

<h3>OBJECTIVE</h3> To determine the ability of basic calcium phosphate (BCP) crystals to induce (<i>a</i>) mitogenesis, matrix metalloproteinase (MMP)-1, and MMP-13 in human osteoarthritic synovial fibroblasts (HOAS) (<i>b</i>) cultured porcine articular chondrocytes. <h3>METHODS</h3> Mitogenesis HOAS was measured by [<sup>3</sup>H]thymidine incorporation assay counts cells monolayer culture. MMP messenger RNA (mRNA) accumulation determined either northern blot analysis or reverse...

10.1136/ard.60.4.399 article EN Annals of the Rheumatic Diseases 2001-04-01

Synovial fluid basic calcium phosphate (BCP) crystals are markers of severe joint degeneration in osteoarthritis. BCP cause mitogenesis articular cells and stimulate matrix metalloprotease production, thus promoting degradation tissues. Previous work suggested that crystal-induced cell activation required intracellular crystal dissolution, induction proto-oncogene expression, signal transduction pathways involving protein kinase C mitogen-activated kinases. Here we further elucidate the...

10.1074/jbc.273.52.35161 article EN cc-by Journal of Biological Chemistry 1998-12-01

Key Points In children undergoing tonsillectomy, low VWF levels did not predict surgical bleeding in the absence of major history. Children have lower than adults and these do appear to be associated with bleeding.

10.1182/bloodadvances.2019000992 article EN cc-by-nc-nd Blood Advances 2020-01-06

The von Willebrand factor (VWF) propeptide (VWFpp) is critical for the targeting of VWF multimers to storage granules. VWFpp alone efficiently navigates pathway in AtT-20 and endothelial cells chaperones mature granules when two proteins are expressed cis or trans . To further define role granular sorting, we examined its ability sort an unrelated protein, C3α into regulated secretory pathway. Chimeric constructs α-chain C3 were developed. protein did not cells. expression resulted but no...

10.1161/01.atv.0000017063.36768.87 article EN Arteriosclerosis Thrombosis and Vascular Biology 2002-06-01

This article will discuss the diagnosis and management of von Willebrand disease (VWD) in United States results from Zimmerman Program, a national study VWD. An algorithm is presented to show how we currently approach diagnostic testing for VWD, including potential replacement ristocetin cofactor assay with new factor (VWF)-GPIb binding assay. Results Program type 1 cohort are presented, findings that genetic defects VWF gene most common levels <30 IU/dL, but bleeding symptoms were present...

10.21037/aob.2017.12.05 article EN Annals of Blood 2018-01-26
Coming Soon ...